SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid reports that the US president is considering reclassifying marijuana, which has sparked significant community discussion around potential benefits like tax relief and increased investment.  Traders are actively debating the likelihood and impact of the potential policy change, with some anticipating a major short squeeze while others express skepticism. Overall, the news has injected volatility and renewed interest in cannabis stocks.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending after earnings, with a mixed community sentiment as the stock experiences a sharp sell-off despite strong results and raised guidance, leading to speculation of manipulation and an AI bubble. Discussions revolve around the potential reasons for the decline, including profit-taking, margin concerns, and the overall market rotation out of tech. Despite the negative price action, many analysts have raised their price targets, fueling debate on whether this is a buying opportunity or a sign of further downside.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

Geo Group is trending as analysts updated their target price forecasts, sparking renewed community discussion. Community members are also discussing the company's potential to benefit from shifts in immigration policy and contract wins, while others debate the ethical implications of investing in private prisons. The stock's movement appears tied to broader political and policy cycles related to immigration and detention.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending amid speculation around potential cannabis rescheduling and executive action, driving optimism in the sector. The community is focused on potential catalysts like Trump's actions and Supreme Court decisions that could lead to significant re-rating and M&A activity. Discussions also center on identifying undervalued plays within the cannabis space, particularly those poised for substantial growth if regulatory changes materialize.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending as traders discuss its low float, potential short squeeze, and possible breakout, drawing comparisons to other HK stocks like $SMX and $OCG. Community members are closely watching for a golden cross setup and anticipate upward momentum if the stock moves above the $6 and $8 levels. The stock is known for crazy moves and potential for an after-hours run.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending as investors debate its future, with some citing improving free cash flow and AI potential as reasons to buy, while others express concerns about leadership and profitability. Discussions also center around a potential buyout and the upcoming specs release. Sentiment appears mixed as the stock experiences volatility amid broader market fluctuations.

RYTHM, Inc. engages in the development of hardware and software solutions for indoor agriculture. The company was founded on June 6, 2016 and is headquartered in Rolling Meadows, IL.

RYTHM Inc.

RYTHM Inc. is trending amid community discussions about potential catalysts from its pipeline and high trading volume. Some traders are debating the offering's risk and watching for short covering, while others are focused on technical analysis and potential for a significant price move. Active discussions and user disputes are contributing to the stock's visibility.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

Argo Blockchain is trending due to discussions around its reverse stock split and London Stock Exchange delisting, with the community debating potential impacts. Some traders anticipate a rebound and short squeeze given the low float post-split, while others express skepticism about the company's financial health and potential for further dilution. Overall, the conversation reflects a mix of speculative hope and concern amidst restructuring efforts.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to a surprise CEO exit and a Q3 earnings beat, sparking discussions about the company's future leadership and strategic direction. The approval of a $1B buyback is fueling bullish sentiment, though some express concerns over margin pressure and softness in the Americas. Community members are actively debating whether this marks the start of a sustained turnaround or a temporary reprieve.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending alongside other cannabis stocks amid speculation that the U.S. federal government might ease marijuana restrictions, with community members actively discussing the potential impacts of policy changes. Chatter revolves around an executive order from President Trump to reclassify cannabis, although some traders are wary of potential 'pump and dump' scenarios. Investors are weighing the implications for legacy cannabis companies like ACB given the broader sector's volatile history.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

UBS says this sector remains a high-quality, defensive investment theme

Investing.com -- UBS continues to view the medical devices sector as a high-quality, defensive investment theme, supported by long-term demographic shifts and rising global demand.

Sector ETFs Likely to Gain on May Inflation Data

Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick

Investing.com -- Citi analysts revised their MedTech coverage following a volatile first quarter, with several rating changes and adjustments to target prices.

What Are Wall Street Analysts’ Target Price for Medtronic Stock?

While Medtronic has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink?

Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.

U.S.-China tariff de-escalation is positive for this stock: analyst

Investing.com -- Bank of America analysts say GE HealthCare (NASDAQ:GEHC) should benefit from signs of softening in the U.S.-China trade war, arguing that the worst of the tariff-related pressure may already be priced into the stock.

HSBC shuffles MedTech stocks, cutting 4, upgrading 2

Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading   Siemens  Healthineers AG  (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting  Align Technology  (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&Nephew (LON:SN) to Hold.

A Neuralink rival backed by&nbsp;a former collaborator of Elon Musk has just received FDA clearance for its brain implant. Precision Neuroscience, a fast-growing startup developing brain-computer interface (BCI) technology,&nbsp;announced on Thursday that it has received clearance from the U.S. Food and Drug Administration to market a&nbsp;key component of its implant system for clinical use.&nbsp;The approval signals&nbsp;an increase in competition in the neurotech space, where Elon Musk’s Neuralink has drawn significant public and regulatory attention.The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue.&nbsp;The FDA has cleared it for clinical use in procedures lasting up to 30 days, allowing surgeons to temporarily implant the array to map brain activity.&nbsp;While not the company’s end-use goal, the clearance enables Precision to generate near-term revenue and gather valuable real-world data.Brain-computer interfaces, or BCIs, are designed to translate neural signals into digital commands to power external devices.&nbsp;Precision’s initial focus is on patients with severe paralysis, helping to restore lost functions such as movement and speech.&nbsp;“Neural decoding algorithms, like all AI-driven products, rely on vast amounts of data,” said Rapoport, Precision’s Chief Science Officer. “This regulatory clearance will exponentially increase our access to high-quality data, which will help us build BCI systems that work more effectively.”The Layer 7 device contains 1,024 electrodes packed onto a film thinner than a human hair. It conforms to the brain’s surface, avoiding the need to pierce neural tissue, unlike traditional deep brain stimulation systems used by companies such as Medtronic.The FDA’s decision places Precision in closer competition with Neuralink, which is currently conducting human trials for its implantable device. Other players in the space include Synchron, backed by Amazon’s (AMZN) Jeff Bezos and Microsoft’s (MSFT) Bill Gates.The approval comes at a time when the broader AI and medical device stocks face pressure.The&nbsp;<a href="https://stocktwits.com/symbol/BOTZ">Global X Robotics &amp; Artificial Intelligence ETF</a> (BOTZ), which tracks companies involved in automation and AI, has fallen 17% this year, while the&nbsp;<a href="https://stocktwits.com/symbol/IHI">iShares U.S. Medical Devices ETF</a> (IHI) is down 2.5% amid President Donald Trump’s&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-orders-tariff-probe-on-critical-minerals-escalating-us-china-trade-war-tensions/chQPV2TRbOY">sweeping</a> tariffs, global policy&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/imf-chief-warns-trade-policy-uncertainty-off-the-charts-global-growth-forecast-cut/chQEvFYRbfY">uncertainty</a>, and tighter regulatory scrutiny.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lockheed-martin-stock-drops-after-cfo-jay-malave-steps-down-just-days-before-q1-earnings/chQEM9RRbfN">Lockheed Martin Stock Drops After CFO Jay Malave Steps Down Just Days Before Q1 Earnings</a>

Neuralink, Tesla, and SpaceX founder Elon Musk departs the U.S. Capitol Building on March 5, 2025 in Washington, DC. (Photo by Andrew Harnik/Getty Images)

Elon Musk’s Neuralink Faces New FDA-Approved Rival In Precision Neuroscience

The device, known as the Layer 7 Cortical Interface, is a thin, flexible microelectrode array designed to record and stimulate neural activity without penetrating brain tissue. 

Equity

How Is Teleflex’s Stock Performance Compared to Other Medical Instruments & Supplies Stocks?

Due to Teleflex’s underperformance relative to its industry peers over the past six months, Wall Street analysts remain cautious about the stock’s prospects.

Current Price	$62.05
Prev Close	$62.25
Open	$62.43
Dividend Yield	N/A
50-Day Moving Average	$61.57
Beta	N/A
Avg. Volume	1.28M
PE Ratio	N/A

52-Week High	$65.18
52-Week Low	$52.90
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IHI
iShares US Medical Devices ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IHI News

IHIiShares US Medical Devices ETF